HOCHDORF Group Press Release: Fractional conversion of mandatory convertible bond
Hochdorf, 04 November 2019 – As of today, Amir Mechria will convert three quarters of his stake in the 2017–2020 mandatory convertible bond of HOCHDORF Holding Ltd with a nominal value of CHF 98.25 million. 322,480 shares of HOCHDORF Holding Ltd will thus be allocated to him. This transaction increases the number of outstanding shares of HOCHDORF Holding Ltd to 1,758,369. At the same time, Amir Mechria will become the largest shareholder of the HOCHDORF Group with 18.34%. The voting rights of the HOCHDORF Group are limited to 15% in accordance with the statutes.
At the end of 2016, Amir Mechria sold 51% of Pharmalys Laboratories SA to the HOCHDORF Group. Mechria still holds a 49% stake in Pharmalys Laboratories SA.
Dr Christoph Hug, Head of Corporate Communications HOCHDORF Group, Tel:+41 (0)41 914 65 62 / +41 (0)79 859 19 23, email@example.com.
About the HOCHDORF Group:
The HOCHDORF Group, based in Hochdorf, achieved a consolidated gross sales revenue of CHF 561.0 million in 2018. It is one of the leading foodstuff companies in Switzerland, employing over 694 staff as of 31.12.2018.Made from natural ingredients such as milk, wheat germ and oil seeds, HOCHDORF products have been contributing to our health and wellbeing since 1895 – from babies to senior citizens. Its customers include the food industry and the wholesale and retail sectors. Its products are sold in over 90 countries. The shares are traded on the SIX Swiss Exchange in Zurich (ISIN CH0024666528).